Abiopharma

🔍 Thauberger Matthew (Executive)

Company: Super Micro Computer, Inc. (SMCI)

Report Date: 2026-08-14

Detailed Transactions and Holdings:

• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-14 | Code: H | shares_owned_after: 5,382.00
• Acquired 9,872 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-14 | Code: A | equity_swap_involved: 0 | shares_owned_after: 9,872.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2
• Acquired 21,938 shares of Employee Stock Option (right to buy) at $39.84 per share (Derivative)
  Date: 2026-08-14 | Code: A | Expires: 2036-08-14 | equity_swap_involved: 0 | shares_owned_after: 39,938.00 | transaction_form_type: 4 | Footnotes: F3

Footnotes:

• F1: Each restricted stock unit represents a contingent right to receive one share of SMCI common stock.
• F2: . Subject to the Reporting Person's continued service to SMCI, the restricted stock units vest at the rate of 25% of the total number of units on August 10, 2027 and 1/16th at the end of each three-month period thereafter. Vested units are settled in shares of SMCI common stock.
• F3: Subject to the Reporting Person's continued service to SMCI, the total number of shares subject to the option shall vest and become exercisable at the rate of 1/4th of the shares on the first anniversary of the vesting commencement date on August 14, 2027, and 1/16th at the end of each three-month period thereafter.